Efficacy and safety of anaplastic lymphoma kinase inhibitors for non–small cell lung cancer: A systematic review and network meta‐analysis

BACKGROUND: To assess the efficacy and safety of anaplastic lymphoma kinase inhibitors (ALKIs) for the treatment of advanced‐stage ALK rearrangement‐positive non–small cell lung cancer (NSCLC). METHODS: We searched PubMed, EMBASE, and the Cochrane Library for randomized controlled trials (RCTs) that...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Tzu‐Rong, Liao, Pei‐Fei, Wu, Ta‐Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067357/
https://www.ncbi.nlm.nih.gov/pubmed/36908264
http://dx.doi.org/10.1111/1759-7714.14824

Ejemplares similares

Ejemplares similares